Skip to main content

Advertisement

Log in

NCOA5 low expression correlates with survival in esophageal squamous cell carcinoma

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The nuclear receptor coactivator 5 (NCOA5) was a unique coactivator independent of AF2 that can modulate ERα-mediated transcription. Recent researches have indicated that its downregulation may participate in cancer development and progression. The aims of the present study were to investigate NCOA5 expression in esophageal squamous cell carcinoma (ESCC) and validate its possible influence on patients’ prognosis. NCOA5 expression was examined by immunohistochemical staining in 119 ESCC patients’ tissues. Ten paired tumor and adjacent normal specimens were examined by Western blot analysis. Statistical analysis was performed to assess its relevance with various clinicopathologic features and its influence on patients’ survival. By immunohistochemistry analysis, NCOA5 expression was found to be significantly correlated with differentiation (P = 0.039), T status (P = 0.047) and stage (P = 0.036). Furthermore, we found NCOA5 higher expression in normal tissues than in tumor tissues by Western blot analysis. Univariate analysis showed that poor differentiation (P = 0.035, P = 0.027), lymph node metastasis (P < 0.001, P < 0.001), high T status (P = 0.010, P = 0.012), advanced stage (P < 0.001, P < 0.001) and NCOA5 low expression (P < 0.001, P < 0.001) were significantly correlated with poor prognosis of both disease-free survival (DFS) and overall survival (OS). Multivariate analysis showed that NCOA5 low expression (P = 0.019, P = 0.047), high T status (P = 0.015, P = 0.012), lymph node metastasis (P = 0.040, P = 0.021) and advanced stage (P = 0.017, P = 0.046) were independent prognostic factors of poor DFS and OS. Our findings suggest that NCOA5 low expression is associated with ESCC progression and is a potential biomarker in predicting poor prognosis. Further studies of NCOA5 may help develop new therapeutic strategies against ESCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;9864:400–12.

    Article  Google Scholar 

  2. Qi Y, Chao W, Chiu J. An overview of esophageal squamous cell carcinoma proteomics. J Proteom. 2012;11:3129–37.

    Article  Google Scholar 

  3. Pennathur A, Farkas A, Krasinskas AM, et al. Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg. 2009;4(1048–54):1054–5.

    Google Scholar 

  4. Sauve F, McBroom LDB, Gallant J, et al. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant. Mol Cell Biol. 2001;1:343–53.

    Article  Google Scholar 

  5. Jiang C, Ito M, Piening V, et al. TIP30 interacts with an estrogen receptor-interacting coactivator CIA and regulates C-Myc transcription. J Biol Chem. 2004;26:27781–9.

    Article  Google Scholar 

  6. Lewis JP, Palmer ND, Ellington JB, et al. Analysis of candidate genes on chromosome 20Q12-13.1 reveals evidence for BMI mediated association of PREX1 with type 2 diabetes in European Americans. Genomics. 2010;4:211–9.

    Article  Google Scholar 

  7. Gao S, Li A, Liu F, et al. NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma. Cancer Cell. 2013;6:725–37.

    Article  Google Scholar 

  8. Korkaya H, Kim GI, Davis A, et al. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2 + breast cancer by expanding the cancer stem cell population. Mol Cell. 2012;4:570–84.

    Article  Google Scholar 

  9. Ishimura N, Amano Y, Sanchez-Siles AA, et al. Fatty acid synthase expression in Barrett’s esophagus: implications for carcinogenesis. J Clin Gastroenterol. 2011;8:665–72.

    Article  Google Scholar 

  10. Svensson C, Ceder J, Iglesias-Gato D, et al. REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer. Nucleic Acids Res. 2014;2:999–1015.

    Article  Google Scholar 

  11. Ischenko I, Liu J, Petrenko O, et al. Transforming growth factor-beta signaling network regulates plasticity and lineage commitment of lung cancer cells. Cell Death Differ. 2014;21:1218–28.

    Article  CAS  PubMed  Google Scholar 

  12. Li S, Tian H, Yue W, et al. Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Ann Surg Oncol. 2011;7:2048–56.

    Article  Google Scholar 

  13. Elinav E, Nowarski R, Thaiss CA, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;11:759–71.

    Article  Google Scholar 

  14. Sugimura K, Miyata H, Tanaka K, et al. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin Cancer Res. 2012;18:5144–53.

    Article  CAS  PubMed  Google Scholar 

  15. Timme S, Ihde S, Fichter CD, et al. STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett’S adenocarcinomas. Oncogene. 2014;33:3256–66.

    Article  CAS  PubMed  Google Scholar 

  16. Roderick JE, Tesell J, Shultz LD, et al. C-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells. Blood. 2014;7:1040–50.

    Article  Google Scholar 

  17. Masui K, Tanaka K, Akhavan D, et al. MTOR complex 2 controls glycolytic metabolism in glioblastoma through foxo acetylation and upregulation of c-Myc. Cell Metab. 2013;5:726–39.

    Article  Google Scholar 

  18. Yu L, Wu WK, Li ZJ, et al. Prostaglandin E(2) promotes cell proliferation via protein kinase c/extracellular signal regulated kinase pathway-dependent induction of c-myc expression in human esophageal squamous cell carcinoma cells. Int J Cancer. 2009;11:2540–6.

    Article  Google Scholar 

Download references

Acknowledgments

This work was partially supported by the National Natural Science Foundation of China (No. 30571844), the Science and Technology Development Foundation of Shandong Province (No. 2009GG10002007), the National Natural Science Foundation of Shandong Province (No. ZR2009CM090) and the Independent Innovation Foundation of Shandong University (2012DX005).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hui Tian.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, Gq., Tian, H., Yue, Wm. et al. NCOA5 low expression correlates with survival in esophageal squamous cell carcinoma. Med Oncol 31, 376 (2014). https://doi.org/10.1007/s12032-014-0376-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0376-y

Keywords

Navigation